Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Bionano Genomics Inc (BNGO)

NASDAQ
Currency in USD
Disclaimer
0.7861
+0.0271(+3.57%)
Closed
After Hours
0.7760-0.0101(-1.2848%)

BNGO Comments

this is a volatile stock but if they are leader and keep this position, there is no reason for orofit. young horse are never easy to bet on but if correct, ....
Yes it does, we beat earnings and we have Saphyr sales in England, Canada, Harvard, lots of countries in Europe, Utah and other universities in USA , the list in endless, so I am very Bullish you bear...You are wrong...
I agree with you!
Perdón, después del "Si", hay una coma, porque me deja alguna duda Marcos...... sobre todo cuando dices "estas equivocado". Saludos.
They have sales? But that does not mean they have a profit
BNGO has no profit and revenue, they only have a hope.
When I look at your comment history, you emphasize to yourself quite clearly that you are shorting! :)
man you a bot. be in amc talk that same B-S
This is way overdue for a massive correction...
you mean more than a 50-70% WE already has since february ?
Perdón Fred, no logro entender lo que está queriendo decir....Podrías explicarlo un poquito....gracias.
https://bionanogenomics.com/videos/optical-genome-mapping-unrivaled-structural-variant-detection-for-cancer-research-and-precision-medicine-3/ I BOUGHT THE DIP TODAY...
Dump this trash
why is so red today??
This is so oversold. Be greedy when others are fearful...
Look at the chart on the 5hr. It failed to break the prior high of $10. Now its closing a gap and couldneasily take out $4.65
Correct!
I hear rocket comment all the time, result is *******
This is huge, get your tickets before we launch, also earning coming next month!
Thanks for your recomendation!
Bionano Genomics Announces Significant Progress in China with WeHealth Shanghai’s Adoption of Bionano’s Saphyr System and the Demonstration by Various Institutions of Optical Genome Mapping in Reproductive Health and Genetics https://www.globenewswire.com/news-release/2021/07/06/2258189/0/en/Bionano-Genomics-Announces-Significant-Progress-in-China-with-WeHealth-Shanghai-s-Adoption-of-Bionano-s-Saphyr-System-and-the-Demonstration-by-Various-Institutions-of-Optical-Genom.html
Buying more today
Like "OPK" : /
mjwl
I have 2920 stocks at a avg pice of 3,3 Euro. Should i Sell?
Yes
4 now.yes
yes
Just got ✌ words RUSSELL 2K, poised for earnings.
call writers to get burned
Fools get scared. Hit 50% fib retrace to the penny and went up! All on a fib time ratio day of 161.8%. That was the bottom of leg 2 from high of $9.12.
Game over?
📢 The door on the elevator up is closing!!!
Buy time ? Or should we except 5s
buy
Waoooooo, the gap is filled, now, time to go up!
That is the way! now we will close that one at 4,4 USD
Sell!
buy
All aboard????🚢
...
...
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.